These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 191583)

  • 21. [Two years of experience with viomycin pantothenate-sulfate (vionactan) in the treatment of pulmonary tuberculosis].
    SCALFI GF; PONTIGGIA P; ROSSA G
    Minerva Med; 1958 Sep; 49(71):3343-56. PubMed ID: 13600139
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of viomycin, an anti-tuberculosis antibiotic: copper(ii) coordination, DNA degradation and the impact on delta ribozyme cleavage activity.
    Stokowa-Sołtys K; Barbosa NA; Kasprowicz A; Wieczorek R; Gaggelli N; Gaggelli E; Valensin G; Wrzesiński J; Ciesiołka J; Kuliński T; Szczepanik W; Jeżowska-Bojczuk M
    Dalton Trans; 2016 May; 45(20):8645-58. PubMed ID: 27143296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total structure of capreomycin IB, a tuberculostatic peptide antibiotic.
    Bycroft BW; Cameron D; Croft LR; Hassanali-Walji A; Johnson AW; Webb T
    Nature; 1971 Jun; 231(5301):301-2. PubMed ID: 4325287
    [No Abstract]   [Full Text] [Related]  

  • 24. [Viomycin, a new antibiotic against Koch's bacilli].
    VIDAL PEREZ S
    Clin Lab (Zaragoza); 1951 Aug; 52(305):116-8. PubMed ID: 14887081
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new active antibiotic against Mycobacteria: viomycin].
    NITTI V
    Arch Tisiol Mal Appar Respir; 1951 Aug; 6(8):Varia, 299-304. PubMed ID: 14878565
    [No Abstract]   [Full Text] [Related]  

  • 26. Conformational studies of oxytocin, lysine vasopressin, arginine vasopressin, and arginine vasotocin by carbon-13 nuclear magnetic resonance spectroscopy.
    Walter R; Prasad KU; Deslauriers R; Smith IC
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2086-90. PubMed ID: 4516207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton nuclear magnetic resonance studies of the association of ribonuclease S-peptide and analogs with ribonuclease S-protein.
    Finn FM; Dadok J; Bothner-By AA
    Biochemistry; 1972 Feb; 11(3):455-61. PubMed ID: 5062062
    [No Abstract]   [Full Text] [Related]  

  • 28. Lysine to 13C-labeled homoarginine conversion in microbial cytochromes c. Electron transport rates and 13C nuclear magnetic resonance spectroscopy.
    Kennelly PJ; Timkovich R; Cusanovich MA
    J Mol Biol; 1981 Jan; 145(3):583-602. PubMed ID: 6167726
    [No Abstract]   [Full Text] [Related]  

  • 29. [Some notes and recommendations on the use of the so-called 2d-line chemo-antibiotic antitubercular agents].
    RODRIGUES F
    Med Contemp; 1961 Sep; 79():399-414. PubMed ID: 14493153
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on sensitivity determination of Mycobacterium tuberculosis against chemotherapeutic drugs, with reference to various factors affecting the antibiotic activity of kanamycin and viomycin].
    SUGIYAMA I
    Kekkaku; 1960 Mar; 35():179-86. PubMed ID: 13835578
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation of Ng-Monoethyl-L-arginine.
    Cho YB; Furst G; Paik WK
    Anal Biochem; 1984 Jun; 139(2):377-82. PubMed ID: 6089606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soybean trypsin inhibitor (Kunitz) and its complex with trypsin. Carbon-13 nuclear magnetic resonance studies of the reactive site arginine.
    Baillargeon MW; Laskowski M; Neves DE; Porubcan MA; Santini RE; Markely JL
    Biochemistry; 1980 Dec; 19(25):5703. PubMed ID: 7459339
    [No Abstract]   [Full Text] [Related]  

  • 33. Arginine to citrulline replacement in substrates of phosphorylase kinase.
    Bartleson C; Luo S; Graves DJ; Martin BL
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):23-8. PubMed ID: 11004553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [CHEMO-ANTIBIOTIC THERAPY IN PULMONARY TUBERCULOSIS].
    RUSSO V
    Rass Int Clin Ter; 1963 Sep; 43():1009-13. PubMed ID: 14091636
    [No Abstract]   [Full Text] [Related]  

  • 35. [TREATMENT OF OTOTOXIC MANIFESTATIONS DUE TO ANTITUBERCULAR ANTIBIOTIC THERAPY. CLINICAL USE OF A MONOAMINE OXIDASE INHIBITOR (NIALAMIDE)].
    MEO G; CENZI P
    Gazz Int Med Chir; 1964 Apr; 68():679-89. PubMed ID: 14145734
    [No Abstract]   [Full Text] [Related]  

  • 36. The antibiotic viomycin traps the ribosome in an intermediate state of translocation.
    Ermolenko DN; Spiegel PC; Majumdar ZK; Hickerson RP; Clegg RM; Noller HF
    Nat Struct Mol Biol; 2007 Jun; 14(6):493-7. PubMed ID: 17515906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of viomycin and its acyl derivatives.
    Kitagawa T; Miura T; Taniyama H
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2176-84. PubMed ID: 4346587
    [No Abstract]   [Full Text] [Related]  

  • 38. 31P nuclear magnetic resonance studies of crayfish (Orconectes virilis). The use of inversion spin transfer to monitor enzyme kinetics in vivo.
    Butler KW; Deslauriers R; Geoffrion Y; Storey JM; Storey KB; Smith IC; Somorjai RL
    Eur J Biochem; 1985 May; 149(1):79-83. PubMed ID: 3996405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Viomycin, new antituberculosis drug].
    BARTOLOZZI G
    Riv Clin Pediatr; 1951 Mar; 49(3):121-31. PubMed ID: 14845536
    [No Abstract]   [Full Text] [Related]  

  • 40. Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.
    Li X; Li Y; Han H; Miller DW; Wang G
    J Am Chem Soc; 2006 May; 128(17):5776-85. PubMed ID: 16637646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.